IndustryCompany release

Novavax lifts 2026 revenue guidance after $125M Sanofi combination-vaccine milestone

🇺🇸 Novavax Inc (NVAX) · Thu 05 Nov 2026

The US vaccine developer reported $68 million in third-quarter revenue and a $31 million net loss, with cash of $627 million at the end of the period.

Novavax reported its third-quarter 2026 results on 5 November, posting revenue of $68 million and a net loss of $31 million. The company said it held $627 million in cash.

It raised its full-year adjusted revenue guidance to about $400 million at the midpoint. The increase was helped by a $125 million milestone payment, which the company earned after its partner Sanofi began a European Phase 3 trial of a combined influenza and COVID-19 vaccine.

Sanofi plans to run a US Phase 3 trial of the combination vaccine in 2027. According to the company's summary, that study is intended to support an application for approval from the US Food and Drug Administration.

Novavax also said its vaccine candidate against Clostridioides difficile (C. difficile) could enter clinical testing as early as 2027.

What it means for your team

  • Regulatory teams tracking combination respiratory vaccines should note the sequencing: a European Phase 3 trial is under way, and a US Phase 3 trial intended for FDA approval is planned for 2027.
  • The milestone payment ties Novavax's financial outlook directly to partner-led clinical progress, which is relevant for market-access analysts assessing the company's pipeline.
  • Pharmacovigilance and clinical teams may wish to watch for trial registry updates as the combination programme advances, since the source gives no further trial design detail.
  • A C. difficile vaccine entering the clinic as early as 2027 would add a new, non-respiratory candidate to the company's development pipeline.

Company's press release (SEC filing): Novavax Inc ↗

Article written by VigiEye from the official source (Novavax Inc). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →